Skip to content
Screener

MiMedx Group MDXG Free cash flow

Free cash flow at other companies

IAR
Integra LifeSciencesIART
$10.5M+193%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$91K+155%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-$32.75M+10.3%
Solventum logo
SolventumSOLV
-$273M-241%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$1.97M-86.3%
CorMedix logo
CorMedixCRMD
$41.65M+111%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Calculated from MiMedx Group’s reported figures.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071

FAQ

What is MiMedx Group's free cash flow?
MiMedx Group (MDXG) reported free cash flow of -$10.61M in Q2 2026.
How has MiMedx Group's free cash flow changed year-over-year?
MiMedx Group's free cash flow decreased by 174.5% year-over-year, from $14.24M to -$10.61M.
What is the long-term trend for MiMedx Group's free cash flow?
Over 3 years (2022 to 2025), MiMedx Group's free cash flow has grown at a 53.9% compound annual growth rate (CAGR), from -$20.02M to $72.97M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about MiMedx Group's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude